The orphan drug program overseen by the FDA is loaded with government incentives and has helped hundreds of thousands of patients feel better or... High prices for orphan drugs strain families, insurers

The orphan drug program overseen by the FDA is loaded with government incentives and has helped hundreds of thousands of patients feel better or even stay alive, but the program has opened the door to almost unlimited price tags and created incentives for drug makers to cash in, and to cash in repeatedly.


Sign up for our free email alerts and follow us on Facebook and on Twitter @gahealthnews.
Help us fulfill our nonprofit mission with a tax-deductible donation!

Kaiser Health News

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

Please leave these two fields as-is:

Help us pursue our nonprofit mission with a tax-deductible donation.

Credit Cards

EVERY LITTLE BIT HELPS
Donations Welcome

Donate Icon